Evert Küppers is an all-rounded executive with over 25 years of operational experience in pharma & biotech focusing on business & corporate development, fundraising, and R&D operations.
As biotech CEO in Germany, Switzerland and Belgium/UK, he successfully led cross-functional, international management and R&D teams and closed multiple investment rounds with international, blue-chip US/EU investors, as well as, private/public investors.
Recently, he was a Venture Partner with NLC, a healthtech venture builder, for which he established three MedTech companies (Bologna, Bremen/Vienna, Nijmegen). He is currently also CEO of BOOST Pharma, a Copenhagen-based clinical-stage cell therapy biotech.
Evert is an educated biomedical scientist (MSc., Leiden University, NL) and obtained an MBA degree from the RSM/Erasmus University, NL. He is fluent in Dutch, German, English and Spanish and lives with his family in Munich, Germany. LinkedIn profile